The drug has met all of the Food and Drug Administration's requirements but is facing an automatic stay as the result of litigation with Sanofi, who has claimed patent infringement on it Lantus insulin.
The pharmacy chain highlighted the collaborative practice agreement as a way for physicians to take part in new Centers for Medicare and Medicaid Services alternative payment models that allow physicians to be reimbursed for services that pharmacies can help them provide.
At the POLITICO Pro Health Care Briefing on Medicaid as a Driver of Care Innovation in the States, CVS Health chief policy and external affairs officer Tom Moriarty highlighted the role that pharmacists can play in helping reach patients with chronic conditions and improve their adherence through personalized interactions and how accessible care through retail clinics can reduce healthcare costs.
In addition to the timeline and visual logbook, new features include a fingerprint login, an events newsfeed featuring diabetes-related articles, set reminders and a break out of pre- and post-meal tagged results.
Challenge participants who have diabetes will use Ascensia’s Contour Next One Blood Glucose Monitoring System to monitor their blood glucose, and all participants will use higi, the largest self-screening network in the nation, to monitor weight and body mass index.
CNBC on Wednesday reported that Apple has hired a small team of engineers as part of a "secret" initiative to develop the next generation of diabetes management devices. "The initiative is far enough along that Apple has been conducting feasibility trials at clinical sites across the Bay Area and has hired consultants to help it figure out the regulatory pathways," CNBC reported, citing sources familiar with the effort. "Apple isn't the only technology company eyeing opportunities in the space, [however]. Verily, Google's life sciences team, is currently working on a 'smart' contact lens to measure blood sugar via the eye, and it partnered up with DexCom in 2015." (CNBC)
According to Dexcom, its continuous glucose monitoring system is proven to significantly lower A1C levels resulting in lowered medical costs from diabetes complications (e.g., ER visits, seizures, etc.) and is now the only device approved for CGM for Medicare.
Through April 30, there will be free, guided tours at 400 of the company’s stores with in-store pharmacies under the Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, ACME, Tom Thumb, Randalls, Pavilions, Star Market and Carrs banners.